Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis.

Alberto San Francisco RamosCarolina Liu SanchezTatiana Bovill RoseDavid SmithNatasha ThornEva GalizaThahmena MiahJennifer PearceCecilia HultinCatherine CosgroveYingfen HsiaPaul T Heath

Published in: Expert review of vaccines (2024)

COVID-19 vaccine booster schedules have distinct reactogenicity profiles, dependent on dose and vaccine type, which may allow targeted recommendations and provide choice for specific populations. Greater standardization of adverse event reporting will aid future studies.

Keyphrases

coronavirus disease
sars cov
adverse drug
current status
respiratory syndrome coronavirus
decision making
case control
electronic health record